Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of an Exhaled Breath Electronic Nose Platform for Multi-Disease Risk Prescreening: A Prospective Multicenter Study

NCT07804017 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT07804017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07804017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of an Exhaled Breath Electronic Nose Platform for Multi-Disease Risk Prescreening: A Prospective Multicenter Study
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 1, 2028
Enrollment
20,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic respiratory disease, endocrine disease, lung cancer, metabolic disease, pulmonary nodule